Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-3.87%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.66%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.24%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.07 Perf Half Y21.67%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-19.76%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.12 - 80.35 Perf YTD-12.98%
Dividend0.30 P/FCF- EPS past 5Y- ROI- 52W High-24.03% Beta-
Dividend %0.49% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low38.34% ATR1.60
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.08 Volatility3.46% 2.54%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.68 Prev Close61.10
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.45M Price61.04
Recom- SMA20-2.45% SMA503.68% SMA2006.03% Volume5,092,746 Change-0.10%
Aug-29-16 10:43AM  Biotech Stocks: Look Who's Selling at
Aug-26-16 10:27AM  Biotech ETFs in Focus After Mylan's EpiPen Controversy
08:04AM  Could Zinbryta Become a Novel Immunomodulatory Therapy for MS?
Aug-25-16 02:14PM  Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks
Aug-24-16 02:37PM  How Advisors Evaluate Industry, Sector ETFs
11:04AM  Medivation: The Latest Analyst Recommendations
Aug-23-16 08:16AM  It Could Be An Interesting Ride For Healthcare ETFs
Aug-22-16 12:46PM  Medivation shareholders should be thrilled about price of Pfizer deal: analysts at MarketWatch
Aug-17-16 06:46AM  Healthcare Investors May Be Pricing In A Clinton Victory
Aug-16-16 12:36PM  Charting the U.S. benchmarks pulling-teeth breakout attempt at MarketWatch
11:08AM  Tuesday links: operating in silos
06:07AM  US Consumer Sentiment Is Below the Forecast
Aug-15-16 02:58PM  Bulls are chasing uptrend in biotech fund
11:58AM  Biotech Stocks: The Rebirth of the Bull? at
Aug-11-16 11:58AM  Active Traders Turn Bullish on Biotech at Investopedia
Aug-09-16 10:15AM  Crushed Bio-Tech leader falls 90%, now attempting breakout
Aug-06-16 11:16AM  The Week Ahead: Is Macro Really Wacko? at Forbes
Aug-05-16 09:07AM  Why Markets Remained Range Bound after US Data Release
Aug-04-16 10:00AM  Amid Biotech Rally, Investors Show Jitters
Aug-02-16 05:00PM  Biogen surges on takeover talk. 4 Trades
04:09PM  2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?
09:08AM  Is BioMarin Set to Become Profitable in 2017?
09:05AM  How Significant Is Alexions Opportunity with Soliris?
07:57AM  Weak US Data: ISM Manufacturing PMI and Construction Spending
06:59AM  Talk about risk on: The unpredictable biotech sector just entered a bull market at MarketWatch
Aug-01-16 12:33PM  Why Did the US Dollar Index Fall Last Week?
12:33PM  Biotech bounce
10:22AM  Investor buys time for a rally in biotechs
Jul-30-16 11:12AM  The Week Ahead: Bull Sheds Sheep's Clothing at Forbes
Jul-29-16 11:58AM  Biotech Stocks: The End of Political Risk? at
11:21AM  Best ETFs of July
Jul-28-16 01:58PM  Celgene Set to Squeeze Short Sellers (CELG, IBB) at Investopedia
09:11AM  FOMC Keeps the Door Open for a Live Meeting in September
07:00AM  A Trump win could also be a win for these volatile stocks at CNBC
Jul-25-16 12:06PM  Yee: Biotech stocks will outperform after election
12:00PM  Bracing for a 'bio-wreck'?
05:00AM  This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles
Jul-22-16 01:12PM  Will Orenitram Lose Market Share to Uptravi in 2016?
Jul-21-16 12:00PM  Is biotech back?
Jul-19-16 04:21PM  Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why at Motley Fool
Jul-18-16 11:07AM  How Much Potential Does Promacta Hold?
Jul-14-16 01:11PM  Ligand Pharmaceuticalss Performance Based on EV-to-EBITDA
11:05AM  ALNY Reports Positive Results from Open Label Extension Study of Revusiran
Jul-13-16 02:35PM  New Stock Market Highs Fighting Many More Outside Pressures Than Usual: Time to Panic? at 24/7 Wall St.
09:00AM  Biotech ETFs: Will the Once Hot Group Rebound?
Jul-07-16 12:18PM  Strong ISM Non-Manufacturing PMI Overshadows Services PMI
Jul-05-16 11:05AM  AbbVies Tests of Imbruvica with Venclexta for Oncology Therapy
Jul-01-16 04:06PM  Biotech Bottom Calls After Big Bounce (IBB, XBI) at Investopedia
11:07AM  What Are the Benefits of the Novartis-Xencor Alliance to Xencor?
07:01AM  Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
Jun-30-16 06:33PM  Biotechs Building Base?...Or Bursting Bubble?
03:54PM  How Did Investors Respond to the Novartis-Xencor Alliance?
03:54PM  The Novartis-Xencor Collaboration Agreement: The Details
02:21PM  Hedge Funds Like ETFs Too
08:21AM  US Inflation Numbers Are Decent, Brexit Clouds Future Outlook
Jun-29-16 07:00AM  US GDP and Consumer Confidence: Is a Revival Coming?
Jun-26-16 07:21AM  The 5 Best Healthcare ETFs at Motley Fool
Jun-24-16 09:56AM  Brexit means little for biotech stocks, analyst says at MarketWatch
Jun-22-16 02:07PM  Traders Get It Right (Sort Of) With Leveraged Biotech ETFs
Jun-21-16 01:09PM  Bio Tech; Market leader testing breakdown level
Jun-16-16 10:46AM  Why Does XBIs Loss Continue to Widen?
Jun-15-16 11:50AM  Biotech: It's the Election, Silly at
09:16AM  Cellectar's stock soars after positive results of a study of its tumor treatment at MarketWatch
Jun-14-16 03:32PM  Biotech: Still Troubled at
07:00AM  IBB & XBI: Should You Short the Biotech Industry? at Investopedia
Jun-13-16 02:00PM  3 Cases When Not to Place Tight Stop-Loss Orders (IBB, XBI) at Investopedia
09:06AM  How Are XBIs Holdings Moving Averages Trending?
Jun-10-16 03:58PM  Downside Ahead For Biotech Stocks?
Jun-07-16 12:44PM  Yellen Upbeat on Economy: Wining Sector ETFs
12:33AM  Biotech Bounce: Sizzle Or Fizzle?
Jun-06-16 03:34PM  How Did Biotech ETFs Perform in the Week Ended June 3?
07:47AM  Exelixis's stock surges after positive results from trial of kidney cancer treatment at MarketWatch
Jun-03-16 01:20PM  The buzz from ASCO
11:22AM  ADP Unemployment Change Decent: Initial Jobless Claims Fall
09:06AM  Heres What Else Is Happening Now for Ionis
08:00AM  Trying to Believe in Biotech ETFs
Jun-02-16 04:08PM  6 Biotechs Seriously on the Move at 24/7 Wall St.
10:23AM  Biotech Stocks: Don't Expect a 'Miraculous Recovery' at
07:51AM  A.M. Funds Roundup: DoubleLine Hits $100B; Big Trading in Small-Cap Index Funds at
Jun-01-16 06:07PM  Inside Ioniss Key Pipeline Drug IONIS-TTR
09:23AM  3 High-Growth ETFs to Supercharge Your Portfolio at Motley Fool
May-31-16 05:58PM  What Happened to Ioniss Revenues in 1Q16?
03:26PM  A Lesson in Biotech Risk at
09:21AM  XBI Tops the Biotechnology ETFs in the Last Week of May
May-27-16 02:05PM  XBI Mid-Caps: Seattle Genetics Rose Due to Higher Trading Volumes
01:11PM  This Biotech ETF Could Be Ready To Party
01:02PM  3 Highly Rated IBD Stocks Powering A Top Biotech ETFs Revival
May-23-16 05:44PM  Markets Rise as Fed Member James Bullard Exhibits Hawkish Stance
May-19-16 12:16PM  XBI Large-Caps: Why Is BioMarin Inching Higher?
12:16PM  Markets Are Defensive: XBI Outperforms the Market
May-17-16 11:40AM  Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May-16-16 10:07AM  Analyzing XBI Mid-Caps: Intrexon Fell Due to 1Q16 Loss
10:06AM  What Do Analysts Recommend for Medivation?
May-13-16 04:48PM  What Lies Ahead for Biotech ETFs?
May-12-16 12:13PM  Inside XBI Large-Caps: European Commission Approves of Empliciti
12:13PM  XBI Dropped, Markets Fell Due to Retail Sector Concerns
May-10-16 04:13PM  Why Did Medivations Share Price Increase so Much after Earnings?
07:00AM  The Trader Daily: Lots of Stocks Get Drilled at TheStreet
07:00AM  The Trader Daily: Lots of Stocks Get Drilled
May-09-16 06:24PM  Healthcare, Biotech SPDR Indexes Gain on May 9 as US Dollar Rises
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.